We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

129 hedge funds and large institutions have $522M invested in Amphastar Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 42 increasing their positions, 53 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $489M → $522M (+$33.5M)

0.4% less ownership

Funds ownership: 55.13% → 54.73% (-0.4%)

5% less funds holding

Funds holding: 136 → 129 (-7)

21% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 53

44% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 16

Holders
129
Holders Change
-7
Holders Change %
-5.15%
% of All Funds
2.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
42
Reduced
53
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$9.45M
2
BlackRock
BlackRock
New York
+$4.69M
3
Morgan Stanley
Morgan Stanley
New York
+$4.57M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.33M
5
Prudential Financial
Prudential Financial
New Jersey
+$1.18M

Top Sellers

Rank Fund Capital Flow
1
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$5.28M
2
Two Sigma Investments
Two Sigma Investments
New York
-$3.54M
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$2.36M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$2.25M
5
AL
AJO LP
Pennsylvania
-$2.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCIA
76
Campbell & Co Investment Adviser
Maryland
$314K -$9.73K -500 -3%
Royal Bank of Canada
77
Royal Bank of Canada
Ontario, Canada
$307K +$1.95K +100 +0.7%
BNP Paribas Financial Markets
78
BNP Paribas Financial Markets
France
$300K -$18.2K -933 -6%
DekaBank Deutsche Girozentrale
79
DekaBank Deutsche Girozentrale
Germany
$299K – – –
OPERF
80
Oregon Public Employees Retirement Fund
Oregon
$293K -$4.48K -230 -2%
Citigroup
81
Citigroup
New York
$292K +$140K +7,197 +98%
Public Employees Retirement Association of Colorado
82
Public Employees Retirement Association of Colorado
Colorado
$276K – – –
RJA
83
Raymond James & Associates
Florida
$275K -$28.8K -1,481 -10%
MSA
84
Mason Street Advisors
Wisconsin
$274K -$1.52K -78 -0.6%
Victory Capital Management
85
Victory Capital Management
Texas
$273K +$20.4K +1,050 +8%
D.E. Shaw & Co
86
D.E. Shaw & Co
New York
$259K +$251K +12,887 New
State of Tennessee, Department of Treasury
87
State of Tennessee, Department of Treasury
Tennessee
$254K +$21.7K +1,116 +10%
RHBC
88
R.H. Bluestein & Co
Michigan
$251K -$48.6K -2,500 -17%
MLICM
89
Metropolitan Life Insurance Company (MetLife)
New York
$245K – – –
FTDI
90
First Trust Direct Indexing
Massachusetts
$233K +$226K +11,592 New
ASRS
91
Arizona State Retirement System
Arizona
$222K -$2.65K -136 -1%
Bank of Montreal
92
Bank of Montreal
Ontario, Canada
$217K -$2.36M -121,463 -92%
Squarepoint
93
Squarepoint
New York
$215K -$154K -7,921 -43%
EA
94
Ellsworth Advisors
Ohio
$207K +$200K +10,295 New
Susquehanna International Group
95
Susquehanna International Group
Pennsylvania
$201K -$484K -24,860 -71%
PAM
96
Panagora Asset Management
Massachusetts
$185K +$24.8K +1,276 +16%
Russell Investments Group
97
Russell Investments Group
United Kingdom
$171K – – –
TRSOTSOK
98
Teachers Retirement System of the State of Kentucky
Kentucky
$141K – – –
Acadian Asset Management
99
Acadian Asset Management
Massachusetts
$112K -$236K -12,118 -69%
Zurich Cantonal Bank
100
Zurich Cantonal Bank
Switzerland
$107K – – –
2 3
4
5 6

AMPH Hedge Fund Activity: Q4 2020 in Review

129 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q4 2020, worth a combined $522M — up 6.9% from $489M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of AMPH and 9 opened new positions — a net loss of 7 holders — while 53 trimmed existing stakes and 42 added.

The largest buyer was Federated Hermes, adding an estimated $9.45M. The largest seller was Fuller & Thaler Asset Management, cutting an estimated $5.28M.

  • 129 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q4 2020, down from 136 in Q3 2020.
  • Funds reported $522M of Amphastar Pharmaceuticals stock for Q4 2020, up 6.9% quarter-over-quarter.
  • 9 funds opened new Amphastar Pharmaceuticals positions in Q4 2020 and 16 closed out, a net change of -7 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q4 2020 was Federated Hermes, an estimated $9.45M added.
  • The largest Amphastar Pharmaceuticals seller in Q4 2020 was Fuller & Thaler Asset Management, an estimated $5.28M sold.

Based on aggregated 13F filings for Q4 2020.